Dysruptek, LLC – Trademark Portfolio

Entity Type: 16

Dysruptek, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include HERO, DYSRUPTEK, BLUEDIAMOND, and BLUEDIAMOND CONSTRUCTION SUPPLY. The owner is based in Jacksonville, FL.

111 Riverside Avenue

Jacksonville, FL 32202

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Dysruptek, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (5 filings)

Scientific and technological services; industrial analysis and research services

36
Insurance & Financial (2 filings)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does Dysruptek, LLC have?

Dysruptek, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.

What trademark classes does Dysruptek, LLC file in?

Dysruptek, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Dysruptek, LLC's most well-known trademarks?

Dysruptek, LLC's registered trademark portfolio includes well-known marks such as HERO, DYSRUPTEK, BLUEDIAMOND, and BLUEDIAMOND CONSTRUCTION SUPPLY. These are among 5 currently registered trademarks in the portfolio.

What is Dysruptek, LLC's trademark registration success rate?

Dysruptek, LLC has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.